Vickerman P - Search Results

1

Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis.

Cunningham EB, Wheeler A, Hajarizadeh B, French CE, Roche R, Marshall AD, Fontaine G, Conway A, Bajis S, Valencia BM, Presseau J, Ward JW, Degenhardt L, Dore GJ, Hickman M, Vickerman P, Grebely J. Cunningham EB, et al. Among authors: vickerman p. Int J Drug Policy. 2023 Jan;111:103917. doi: 10.1016/j.drugpo.2022.103917. Epub 2022 Dec 19. Int J Drug Policy. 2023. PMID: 36542883

2

Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users.

Vickerman P, Hickman M, Rhodes T, Watts C. Vickerman P, et al. J Acquir Immune Defic Syndr. 2006 Jul;42(3):355-61. doi: 10.1097/01.qai.0000219788.73539.47. J Acquir Immune Defic Syndr. 2006. PMID: 16645549

3

Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.

Vickerman P, Hickman M, Judd A. Vickerman P, et al. Int J Epidemiol. 2007 Apr;36(2):396-405. doi: 10.1093/ije/dyl276. Epub 2007 Jan 11. Int J Epidemiol. 2007. PMID: 17218325

4

Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales.

Hickman M, Vickerman P, Macleod J, Kirkbride J, Jones PB. Hickman M, et al. Among authors: vickerman p. Addiction. 2007 Apr;102(4):597-606. doi: 10.1111/j.1360-0443.2006.01710.x. Addiction. 2007. PMID: 17362293

5

Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England.

Hope V, Kimber J, Vickerman P, Hickman M, Ncube F. Hope V, et al. Among authors: vickerman p. BMC Infect Dis. 2008 Sep 18;8:120. doi: 10.1186/1471-2334-8-120. BMC Infect Dis. 2008. PMID: 18801177 Free PMC article.

6

Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis.

Vickerman P, Hickman M, May M, Kretzschmar M, Wiessing L. Vickerman P, et al. Addiction. 2010 Feb;105(2):311-8. doi: 10.1111/j.1360-0443.2009.02759.x. Epub 2009 Nov 16. Addiction. 2010. PMID: 19922515 Review.

7

Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed.

Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Degenhardt L, et al. Among authors: vickerman p. Lancet. 2010 Jul 24;376(9737):285-301. doi: 10.1016/S0140-6736(10)60742-8. Lancet. 2010. PMID: 20650522

8

Can Hepatitis C virus treatment be used as a prevention strategy? Additional model projections for Australia and elsewhere.

Vickerman P, Martin N, Hickman M. Vickerman P, et al. Drug Alcohol Depend. 2011 Jan 15;113(2-3):83-5; discussion 86-7. doi: 10.1016/j.drugalcdep.2010.08.001. Epub 2010 Sep 15. Drug Alcohol Depend. 2011. PMID: 20832198

9

Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility.

Martin NK, Vickerman P, Foster GR, Hutchinson SJ, Goldberg DJ, Hickman M. Martin NK, et al. Among authors: vickerman p. J Hepatol. 2011 Jun;54(6):1137-44. doi: 10.1016/j.jhep.2010.08.029. Epub 2011 Feb 12. J Hepatol. 2011. PMID: 21145810

10

Mathematical modelling of hepatitis C treatment for injecting drug users.

Martin NK, Vickerman P, Hickman M. Martin NK, et al. Among authors: vickerman p. J Theor Biol. 2011 Apr 7;274(1):58-66. doi: 10.1016/j.jtbi.2010.12.041. Epub 2011 Jan 12. J Theor Biol. 2011. PMID: 21236265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

389 results

Search Page